Related Experiment Videos
Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy
Satoshi Nagata1, Tomoko Ise, Masanori Onda
1Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4264, USA.
Summary
Researchers identified two membrane-specific epitopes (Ep2 and Ep7) on CD30, crucial for targeting lymphomas. These epitopes avoid competition from soluble CD30, offering a promising strategy for more effective CD30 immunotherapy.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- CD30 is a key target in Hodgkin's lymphoma and anaplastic large cell lymphoma immunotherapy.
- Soluble CD30 (sCD30) can interfere with CD30-targeting therapies through competitive binding.
- Identifying CD30 epitopes specific to the cell membrane is crucial for overcoming sCD30-mediated resistance.
Purpose of the Study:
- To identify and characterize novel epitopes on membrane-associated CD30 that are absent on soluble CD30.
- To evaluate the potential of these membrane-specific epitopes as superior targets for CD30-directed immunotherapy.
- To investigate the binding characteristics of anti-CD30 monoclonal antibodies (mAbs) to both membrane and soluble forms of CD30.
Main Methods:
- Characterization of 27 anti-native CD30 monoclonal antibodies (mAbs) against 8 topographical epitopes.
- Preparation of soluble CD30 from cell culture supernatants.
- Enzyme-linked immunosorbent assay (ELISA) and size-exclusion chromatography to assess mAb cross-reactivity and binding to membrane-associated vs. soluble CD30.
Main Results:
- Two epitopes, Ep2 (amino acids 107-153) and Ep7 (amino acids 282-338), demonstrated minimal cross-reactivity (<2%) with soluble CD30.
- These Ep2 and Ep7 specific mAbs effectively bound to cell-associated CD30 even in the presence of excess soluble CD30.
- Membrane-specific mAbs did not form immune complexes with soluble CD30 in mouse serum, unlike mAbs targeting other epitopes.
Conclusions:
- Ep2 and Ep7 represent membrane-specific epitopes on CD30, unaffected by soluble CD30 interference.
- These findings suggest that targeting membrane-specific epitopes could enhance the efficacy of CD30-based immunotherapies.
- The strategy of identifying membrane-specific epitopes may be applicable to other immunotherapy targets.